Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation
Yükleniyor...
Dosyalar
Tarih
2016
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Japan Antibiotics Research Assoc
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
The class A p-lactamase GES-22 has been identified in Acinetobacter baumannii isolates in Turkey, and subsequently shown to differ from GES-11 by a single substitution (M169L). Because M169 is part of the omega loop, a structure that is known to have major effects on substrate selectivity in class A beta-lactamases, we expressed, purified and kinetically characterized this novel variant. Our results show that compared with GES-11(6xHis), GES-22(6xHis) displays more efficient hydrolysis of penicillins, and aztreonam, but a loss of efficiency against ceftazidime. In addition, the M169L substitution confers on GES-22 more efficient hydrolysis of the mechanistic inhibitors clavulanic acid and sulbactam. These effects are highly similar to other mutations at the homologous position in other class A beta-lactamases, suggesting that this methionine has a key structural role in aligning active site residues and in substrate selectivity across the class.
Açıklama
Anahtar Kelimeler
[No Keywords Available]
Kaynak
Journal Of Antibiotics
WoS Q Değeri
N/A
Scopus Q Değeri
Q2
Cilt
69
Sayı
12
Künye
Saral, A., Sandalli, C., Leonard, D. A., June, C. M., Duzgun, A. O., & Cicek, A. C.. (2016). Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation. Journal of Antibiotics, 69(12), 858–862. https://doi.org/10.1038/ja.2016.48
